Effects of protein deficiency on the teratogenicity of cytochalasins in mice.
The developmental toxicity of cytochalasins B (CB) and D (CD) was evaluated in protein-deprived mice. Pregnant CD-1 mice were assigned to control (26%), 16%, 8%, or 4% dietary protein groups on gestation day 1 and dosed by gavage with 0 or 1.5 mg/kg CB or CD on gestation day 8 (plug = day 1). They were killed and subjected to teratological examination on day 18. CD, but not CB, increased prenatal mortality but failed to interact significantly with dietary protein level. Fetal weights were decreased in the 4% and 8% dietary protein groups, but cytochalasin treatment did not exacerbate this effect. Cytochalasin treatment was associated with gross fetal malformations, primarily neural tube defects. Although CB and CD did not significantly increase the percentage of grossly malformed fetuses per litter, the data was suggestive of such an effect, and the incidence of affected litters was increased by cytochalasin treatment in all but the 4% protein group. Skeletal defects, such as jaw malformations, rib or sternebrae variations, and unossified skull bones appeared to be increased by both cytochalasin treatment and dietary protein deficiency. The differences from control values were nonsignificant, however, except for some cases of cytochalasin effects on skull ossification. These results show a general lack of effect of protein deprivation on the developmental toxicity of cytochalasins.
D000014:Abnormalities, Drug-Induced; D000818:Animals; D001842:Bone and Bones / Q000002:abnormalities; D000013:Congenital Abnormalities / Q000209:etiology*; D003571:Cytochalasin B / Q000633:toxicity*; D015638:Cytochalasin D; D003572:Cytochalasins / Q000633:toxicity*; D005314:Embryonic and Fetal Development; D005260:Female; D005865:Gestational Age; D051379:Mice; D011247:Pregnancy; D011248:Pregnancy Complications; D011488:Protein Deficiency / Q000150:complications*
D003572:Cytochalasins; D015638:Cytochalasin D; D003571:Cytochalasin B